BENZPHETAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Benzphetamine Hydrochloride patents expire, and when can generic versions of Benzphetamine Hydrochloride launch?
Benzphetamine Hydrochloride is a drug marketed by Avet Lifesciences, Chartwell, Epic Pharma Llc, Impax Labs, Kvk Tech, Scinopharm Taiwan, Specgx Llc, and Tedor Pharm. and is included in nine NDAs.
The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benzphetamine Hydrochloride
A generic version of BENZPHETAMINE HYDROCHLORIDE was approved as benzphetamine hydrochloride by KVK TECH on July 20th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENZPHETAMINE HYDROCHLORIDE?
- What are the global sales for BENZPHETAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for BENZPHETAMINE HYDROCHLORIDE?
Summary for BENZPHETAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Patent Applications: | 1,427 |
| DailyMed Link: | BENZPHETAMINE HYDROCHLORIDE at DailyMed |
Pharmacology for BENZPHETAMINE HYDROCHLORIDE
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Medical Subject Heading (MeSH) Categories for BENZPHETAMINE HYDROCHLORIDE
US Patents and Regulatory Information for BENZPHETAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 202061-001 | Jan 27, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Kvk Tech | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 090968-001 | Jul 20, 2010 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma Llc | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 040714-001 | Oct 29, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Scinopharm Taiwan | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride | TABLET;ORAL | 040578-001 | Apr 17, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
